Collectively, these observations underscore not only the reproducibility of the PI3K/AKT/mTOR inhibition mechanism when dosage is stringently controlled, but also the critical importance of comprehensively accounting for the molecular background and signaling plasticity of RA-FLSs in the design of valid and clinically meaningful future research protocols. Here, AKT1 is linked to rheumatoid arthritis.